Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 11/20 | 0.59 |
| ▸ | MME | P08473 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.53 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.53 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | CTSL | P07711 | 1/20 | 0.52 |
| ▸ | CTSB | P07858 | 1/20 | 0.52 |
| ▸ | CTSS | P25774 | 1/20 | 0.52 |
| ▸ | CNR1 | P21554 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27832703 | 1.00 | CNR2 (0.59) | CNR2MMEKMT2AMEN1HDAC8 | |
| SCHEMBL6137652 | 1.00 | CNR2 (0.59) | CNR2MMEKMT2AMEN1HDAC8 | |
| SCHEMBL17458667 | 0.86 | CNR2 (0.57) | CNR2KMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL7096702 | 0.86 | CNR2 (0.57) | CNR2KMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL10504767 | 0.86 | ITGB3 (0.65) | CNR2MMEPSMB8PSMB5CTSL | |
| SCHEMBL4144665 | 0.86 | ITGB3 (0.65) | CNR2MMEPSMB8PSMB5CTSL | |
| SCHEMBL4144668 | 0.86 | ITGB3 (0.65) | CNR2MMEPSMB8PSMB5CTSL | |
| SCHEMBL10761117 | 0.85 | KMT2A (0.58) | CNR2KMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL6136287 | 0.84 | POLB (0.59) | CNR2KMT2AMEN1HDAC8HDAC6 | |
| SCHEMBL1499949 | 0.84 | CNR2 (0.57) | CNR2MMEKMT2AMEN1HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240290431-A1 | BIOMARKER AND DIAGNOSIS SYSTEM FOR COLORECTAL CANCER DETECTION | HANGZHOU CALIBRA DIAGNOSTICS CO LTD (CN) | 2024-08-29 | — | — | US | claimed |
| CN-115440375-A | Colorectal cancer prediction system and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-115436633-A | Biomarker for colorectal cancer detection and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-12-06 | — | — | CN | claimed |
| CN-114758719-A | Colorectal cancer prediction system and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-114755422-A | Biomarker for colorectal cancer detection and application thereof | 杭州凯莱谱精准医疗检测技术有限公司 | 2022-07-15 | — | — | CN | claimed |
| EP-1047391-A4 | ALPHA-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | GILLETTE CO (US) | 2005-01-19 | — | — | EP | claimed |
| US-6238655-B1 | USEFUL IN THE FORMULATION OF DEODORANTS, ANTIPERSPIRANTS, BODY SPRAYS, AND OTHER SKIN TREATMENT COMPOSITIONS. | THE GILLETTE COMPANY | 2001-05-29 | — | — | US | claimed |
| EP-1047391-A1 | ALPHA-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 2000-11-02 | — | — | EP | claimed |
| WO-1999030679-A1 | α-AMIDES OF L-AMINO ACIDS AS FRAGRANCE PRECURSORS | THE GILLETTE COMPANY (US) | 1999-06-24 | — | — | WO | claimed |
| EP-0785768-A4 | — | — | 1997-07-30 | — | — | EP | claimed |
| EP-0785768-A1 | O-ACYL SERINES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1997-07-30 | — | — | EP | claimed |
| WO-1995007069-A1 | O-ACYL SERINES AS DEODORANTS | THE GILLETTE COMPANY (US) | 1995-03-16 | — | — | WO | claimed |
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-12458617-B2 | Pet food compositions comprising caprylic acid and docosahexaenoic acid and/or eicosapetaenoic acid for use in treating struvite urolithiasis | HILL'S PET NUTRITION, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-3709817-B2 | COMPOSITIONS COMPRISING OMEGA-3 POLYUNSATURATED AND MEDIUM CHAIN FATTY ACIDS | HILLS PET NUTRITION INC (US) | 2025-10-22 | — | — | EP | disclosed |
| US-20240290431-A1 | BIOMARKER AND DIAGNOSIS SYSTEM FOR COLORECTAL CANCER DETECTION | HANGZHOU CALIBRA DIAGNOSTICS CO LTD (CN) | 2024-08-29 | — | — | US | disclosed |
| US-4533660-A | Antibacterial O-sulfated β-lactam hydroxamic acids | E. R. SQUIBB & SONS, INC. (US) | 1985-08-06 | — | — | US | disclosed |
| EP-0051381-B1 | O-SULFATED BETA-LACTAM HYDROXAMIC ACIDS | E.R. Squibb & Sons, Inc. (US) | 1985-01-30 | — | — | EP | disclosed |
| US-4337197-A | BACTERICIDES | E. R. SQUIBB & SONS, INC. (US) | 1982-06-29 | — | — | US | disclosed |
| EP-0051381-A1 | O-sulfated beta-lactam hydroxamic acids | E.R. Squibb & Sons, Inc. (US) | 1982-05-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034086-A1 | Pet Food Compositions Comprising Caprylic Acid And Docosahexaenoic Acid And/Or Eicosapetaenoic Acid For Use In Treating Struvite Urolithiasis | FPR2, FPR1, FPR3 | CNR2 1062/4885MME 520/4885KMT2A 4550/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.